Zacks Investment Research on MSN
BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential?
Beam Therapeutics BEAM and Intellia Therapeutics NTLA are clinical-stage companies developing investigational gene therapies. While BEAM’s pipeline candidates are still in early-stage development, ...
M OST STORIES about gene-edited children begin with He Jiankui, a rogue Chinese scientist who, in 2018, announced that he had ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
Entrepreneurs say it’s time to safety-test designer baby technology. A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...
The Christian Post on MSN
OpenAI CEO Sam Altman among investors in embryo gene-editing venture
San Francisco-based startup Preventive has raised nearly $30 million from investors, including OpenAI CEO Sam Altman and ...
The new GE technology — for which the Indian Council of Agricultural Research (ICAR) has recently been granted a patent — ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
No doubt the New Zealand Gene Technology Bill, currently awaiting its Second Reading, which will liberalise decisions about gene technology experiments and place them in the hands of a single ...
BOSTON and SEOUL, South Korea, Aug. 26, 2025 /PRNewswire/ -- iNtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering ...
Cibus, Inc., a leading agricultural biotechnology firm, announced that Co-Founder and Interim CEO Peter Beetham will present at the AGP Annual Virtual Healthcare Company Showcase on May 21, 2025. He ...
Three U.S. senators issued a resolution July 15 calling for the development of international ethical standards to govern gene editing research. The resolution was spearheaded by Sens. Dianne Feinstein ...
Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA. Human cells that have been edited with the new retron-based gene editing technology. Orange dots mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results